APT™ Formulation Combats Multi-Drug Resistant Candida auris: An Emerging Global Healthcare Threat Share Article Candida auris is a multi-drug resistant fungus which can be fatal. There is up to a 55% mortality rate if C. auris enters a patients’ bloodstream. Recent studies conducted at Case Western Reserve University, using highly resistant strains of C. auris provided by the Centers for Disease Control (CDC), have demonstrated that APT™ based antifungal formulations are highly effective in killing this deadly fungus on skin surfaces. The APT™ formulations are the only known effective method that has the potential to remove C. auris from the skin of patients and healthcare workers.